Resources

1 Resources for

peter rost

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Q&A: Peter Rost on His Quixotic Bid to Become Obama's FDA Chief
Pfizer whistleblower and compulsive blogger Peter Rost has tossed his Panama hat into the ring for the post of FDA commissioner in the new Obama administration. He's got the "backing" -- or at least the paperwork -- of Sen. Sherrod Brown and Rep. Jo Ann Emerson. Rost...
Tags: FDA, Pfizer Inc., Peter Rost, Federal Government, Government, Jim Edwards
Blog posts 2008-12-04

Additional Resources

The 10 Weirdest Drug Stories of the Month
April 2009 has come and gone, and once again it is time for BNET's roundup of the top 10 weirdest drug stories of the month. Enjoy! Bayer has a flock of sheep mow its lawn About 1450 sheep grazed Bayer's Richmond, Calif., campus last nonth, eating...
Tags: Bayer AG, Pfizer Inc., Pharmaceutical Company, Jim Edwards
Blog posts 2009-05-01
Obama Already Turning Into a Nightmare for Big Pharma
President Barack Obama's new chief of staff, Rahm Emanuel, is turning out to be Big Pharma's worse nightmare. He twice put out press releases backing the crusade of Peter Rost, the former Pfizer vp turned whistleblower, in favor of allowing drug reimportation from foreign countries to encourage price competition. (See...
Tags: Pfizer Inc., Pharmaceutical Company, Research & Development, Business Operations, Jim Edwards
Blog posts 2008-11-07
Between the Lines; A bitter pill.(News)
Byline: Compiled by Joanne Wojcik A Pfizer Inc. executive who is lobbying Congress in support of the reimportation of prescription drugs says his employer is probing his political activities. Dr. Peter Rost, vp of marketing for endocrine care at Byline: Compiled...
Tags: Pfizer Inc.
Research articles 2004-10-04
Document Shows Rogue Bextra Operation Inside Pfizer
The "information" document filed by federal prosecutors against Mary Holloway describes what appears to be a rogue sales unit inside Pfizer dedicated to selling the painkiller Bextra off-label and at unapproved doses. Holloway is believed to be a former Pfizer employee (see Peter Rost's join-the-dots conclusion) although documents in the...
Tags: FDA, Pfizer Inc., Bextra, Holloway, Sales Strategy, Federal Government, Sales Force Management, Sales, Government, Jim Edwards
Blog posts 2009-04-06
The 10 Weirdest Drug Stories of the Month
We're a little late, but here are the 10 weirdest drug stories that popped up onto BNET's radar during March. They were all too small to write about, but too strange to ignore: Did GlaxoSmithKline unwittingly reveal that Wynnona Judd's latest album has been heavily photoshopped? ...
Tags: Career, Jim Edwards, John Mack, Pfizer Inc., Professional Development, Sales, Sales Strategy
Blog posts 2009-04-03
Siemens Takes a Leading Role in the Development of Global Standards for Content; Siemens Representative Peter Rost is Appointed to the ECCMA Board
Business Editors/Hi-Tech Writers
Tags: Siemens AG
Research articles 2001-10-12
Elan's Pennsylvania Lawyer Once Again Makes News
The pressure on Elan Pharmaceuticals CEO Kelly Martin to resign is increasing. Crabtree Partners, an investment company, sent a letter to Elan's board calling for the termination of Martin. But an interesting side-note in this soap opera is the history of Elan's general counsel, Richard Collier. Crabtree...
Tags: Pennsylvania, General Counsel, Elan, Crabtree, Pharmacia, Sales Strategy, Biotechnology, Corporate Governance, Sales Force Management, Sales, Business Operations, Corporate Law, Jim Edwards
Blog posts 2008-12-15
Pharmalot's Ed Silverman: The Exit Interview
On Monday, Pharmalot's Ed Silverman shocked the pharmaceutical business by returning from vacation and announcing that his blog was no more. Over the past two years, Pharmalot grew into the premier supplier of aggregated drug news and a formidable producer of original content even BNET took the Pharmalot feed. In...
Tags: Exit Interview, Blog, Pharmalot, ES, Blogging, Internet, Jim Edwards
Blog posts 2009-01-06
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement